|
|
 |
|
Viewing report
|
|
|
|
Patient Controlled Analgesia: Products, Markets, Players and Outlook
Greystone Associates, Nov 2011
Patient Controlled Analgesia: Products, Markets, Players and Outlook is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.
Pain Management Devices that Address Unmet Patient Needs:
An increasing understanding of the physiology of pain coupled with patient-friendly dosage forms and delivery techniques is providing caregivers and prescribers with improved tools for helping patient manage their own pain. New and emerging pain delivery products that allow patients to play an active role in the timing and dosing of their pain medication - referred to as patient controlled analgesia (PCA) - allow patients to balance pain relief and medication side effects, and potentially improve quality-of-life.
Pain management philosophy is based on the premise of treating pain early and aggressively. This is based on research that pain is tightly correlated with decreased quality of life, and increased incidence of anxiety and depression. Further, pain causes the physiologic release of destructive enzymes that can damage even healthy tissue.
The aging population – particularly in North America and Western Europe, where the quality of medical care is high and consumers enjoy a relatively high standard of living – will create a growing market of mature and elderly needing drug therapies and pain management for a variety of maladies associated with the aging process. These factors are attracting well-financed players and elevating alliance activity in this sector.
Highlights:
- Analyzes and evaluates devices and combination products for patient controlled anlagesia and assesses the market potential for existing and probable future products
- Examines patient controlled analgesia device design issues and evolving market factors
- Analylzes the impact of PCA technology and devices on drug delivery markets for pain management
- Provides market data and forecasts for PCA demand by market segment and region to 2015
- Profiles patient controlled analgesia market sector participants, their product development activity and business strategies
Who Should Buy This Report:
The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare
marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatment segments, and commercial opportunities for self-activated pain management delivery devices with safety features integrated into the device design.
Provider organization business managers, healthcare administrators and investors will also benefit from this study.
|
|
|
|
